Total Payments
$9,141
2024 Payments
$623.21
Companies
31
Transactions
700
Medicare Patients
1,829
Medicare Billing
$255,428
Payment Breakdown by Category
Food & Beverage$9,058 (99.1%)
Education$83.24 (0.9%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $9,058 | 689 | 99.1% |
| Education | $83.24 | 11 | 0.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $1,844 | 180 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $1,145 | 56 | $0 (2024) |
| Merck Sharp & Dohme LLC | $726.83 | 73 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $719.07 | 50 | $0 (2024) |
| Amgen Inc. | $651.53 | 48 | $0 (2024) |
| Amarin Pharma Inc. | $503.86 | 39 | $0 (2022) |
| PFIZER INC. | $369.35 | 30 | $0 (2023) |
| Lilly USA, LLC | $348.43 | 23 | $0 (2023) |
| Currax Pharmaceuticals LLC | $332.33 | 24 | $0 (2024) |
| Esperion Therapeutics, Inc. | $295.56 | 22 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $623.21 | 33 | AstraZeneca Pharmaceuticals LP ($231.65) |
| 2023 | $729.35 | 47 | Novo Nordisk Inc ($130.90) |
| 2022 | $739.76 | 50 | Novo Nordisk Inc ($118.83) |
| 2021 | $1,576 | 118 | Novo Nordisk Inc ($229.70) |
| 2020 | $1,577 | 116 | Novo Nordisk Inc ($278.27) |
| 2019 | $1,061 | 85 | Novo Nordisk Inc ($364.62) |
| 2018 | $1,226 | 103 | Novo Nordisk Inc ($312.63) |
| 2017 | $1,609 | 148 | Novo Nordisk Inc ($272.19) |
All Payment Transactions
700 individual payment records from CMS Open Payments — Page 1 of 28
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/16/2024 | Currax Pharmaceuticals LLC | CONTRAVE (Drug) | Food and Beverage | In-kind items and services | $17.67 | General |
| Category: Obesity | ||||||
| 12/11/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $9.73 | General |
| Category: Obesity | ||||||
| 12/06/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $14.62 | General |
| Category: Respiratory | ||||||
| 12/02/2024 | Vanda Pharmaceuticals Inc. | FANAPT (Drug) | Food and Beverage | In-kind items and services | $27.37 | General |
| Category: SCHIZOPHRENIA | ||||||
| 11/26/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $11.25 | General |
| Category: Diabetes | ||||||
| 11/25/2024 | Currax Pharmaceuticals LLC | CONTRAVE (Drug) | Food and Beverage | In-kind items and services | $16.82 | General |
| Category: Obesity | ||||||
| 11/08/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $17.42 | General |
| Category: Inflammation | ||||||
| 11/07/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $22.03 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/22/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $17.93 | General |
| Category: Diabetes Care | ||||||
| 10/08/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $3.89 | General |
| Category: Diabetes | ||||||
| 09/19/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $23.99 | General |
| Category: DIABETES | ||||||
| 09/12/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $18.22 | General |
| Category: Inflammation | ||||||
| 09/10/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $18.86 | General |
| Category: Obesity | ||||||
| 09/03/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $11.35 | General |
| Category: Diabetes | ||||||
| 08/26/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $14.00 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 08/23/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $16.72 | General |
| Category: Respiratory | ||||||
| 08/15/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $18.20 | General |
| Category: NEUROSCIENCE | ||||||
| 08/12/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $3.38 | General |
| Category: Diabetes | ||||||
| 06/27/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $17.24 | General |
| Category: Inflammation | ||||||
| 06/07/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $13.88 | General |
| Category: Diabetes | ||||||
| 06/04/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $20.61 | General |
| Category: Respiratory | ||||||
| 05/28/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $13.20 | General |
| Category: Diabetes | ||||||
| 05/23/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $16.11 | General |
| Category: Inflammation | ||||||
| 05/22/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $19.52 | General |
| Category: NEUROSCIENCE | ||||||
| 05/10/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $13.60 | General |
| Category: Diabetes Care | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 422 | 1,179 | $216,362 | $61,965 |
| 2022 | 4 | 427 | 1,191 | $216,103 | $59,062 |
| 2021 | 4 | 492 | 1,377 | $244,101 | $72,997 |
| 2020 | 4 | 488 | 1,409 | $251,581 | $61,403 |
Total Patients
1,829
Total Services
5,156
Medicare Billing
$255,428
Procedure Codes
16
All Medicare Procedures & Services
16 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 141 | 533 | $162,032 | $42,061 | 26.0% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 95 | 95 | $34,010 | $11,866 | 34.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 47 | 76 | $15,656 | $4,073 | 26.0% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 139 | 475 | $4,664 | $3,966 | 85.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 149 | 547 | $166,288 | $42,515 | 25.6% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 78 | 78 | $27,665 | $10,050 | 36.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 54 | 89 | $18,334 | $5,084 | 27.7% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 146 | 477 | $3,816 | $1,413 | 37.0% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 167 | 622 | $189,088 | $51,836 | 27.4% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 97 | 97 | $31,137 | $13,059 | 41.9% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 64 | 94 | $19,364 | $6,410 | 33.1% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2021 | 164 | 564 | $4,512 | $1,692 | 37.5% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 170 | 657 | $199,728 | $44,316 | 22.2% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2020 | 99 | 99 | $31,779 | $11,691 | 36.8% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 50 | 75 | $15,450 | $3,691 | 23.9% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2020 | 169 | 578 | $4,624 | $1,705 | 36.9% |
About Dr. Scott Macleod, MD
Dr. Scott Macleod, MD is a Family Medicine healthcare provider based in Woodstock, Virginia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/03/2006. The National Provider Identifier (NPI) number assigned to this provider is 1831157379.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Scott Macleod, MD has received a total of $9,141 in payments from pharmaceutical and medical device companies, with $623.21 received in 2024. These payments were reported across 700 transactions from 31 companies. The most common payment nature is "Food and Beverage" ($9,058).
As a Medicare-enrolled provider, Macleod has provided services to 1,829 Medicare beneficiaries, totaling 5,156 services with total Medicare billing of $255,428. Data is available for 4 years (2020–2023), covering 16 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Location Woodstock, VA
- Active Since 05/03/2006
- Last Updated 08/12/2013
- Taxonomy Code 207Q00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1831157379
Products in Payments
- Ozempic (Drug) $717.41
- FARXIGA (Drug) $657.12
- Vascepa (Drug) $503.86
- JANUVIA (Drug) $436.77
- JARDIANCE (Drug) $433.27
- CONTRAVE (Drug) $317.10
- Saxenda (Drug) $307.23
- Aimovig (Biological) $306.29
- NEXLETOL (Drug) $295.56
- Livalo (Drug) $260.36
- BELSOMRA (Drug) $232.85
- Victoza (Drug) $207.97
- BEVESPI AEROSPHERE (Drug) $203.67
- ELIQUIS (Drug) $199.42
- STIOLTO (Drug) $186.30
- NURTEC ODT (Drug) $179.99
- CHANTIX (Drug) $153.89
- Xultophy 100/3.6 (Drug) $145.77
- TRULICITY (Drug) $142.33
- UBRELVY (Drug) $137.64
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Woodstock
Dr. James Lee, D.o, D.O
Family Medicine — Payments: $12,939
Family Medicine $12,939
Dr. Kirk-Conrod Hewling, Md, MD
Family Medicine — Payments: $10,035
Family Medicine $10,035
Dr. Lata Parvathaneni, Md, MD
Family Medicine — Payments: $7,525
Family Medicine $7,525
Baby Than, Md, MD
Family Medicine — Payments: $7,317
Family Medicine $7,317
Dr. Robert Hudec, Md, MD
Family Medicine — Payments: $7,139
Family Medicine $7,139
Dr. Attri Datta, M.d, M.D
Family Medicine — Payments: $6,173
Family Medicine $6,173